3 of the year’s most notable FDA nods
PharmaVoice
JUNE 27, 2025
Other PrEP regimens on the market require daily oral dosages or shots every few months, but the latest version is only administered twice a year. Now, the WHO’s aggressive goal to “ end HIV/AIDS ” by 2030 could be hampered by dramatic reductions in U.S. While Enhertu pulled in about $3.8
Let's personalize your content